Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise Brinton, Fiona Bruinsma, View ORCID ProfileDaniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, OPAL Study Group, AOCS Group, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant B. Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, V. Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle, Tracy A. O’Mara
doi: https://doi.org/10.1101/2020.04.29.20084095
Dylan M. Glubb
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Deborah J. Thompson
2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Katja K.H. Aben
3Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
4Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands
Ahmad Alsulimani
5Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Frederic Amant
6Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium
Daniela Annibali
6Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium
John Attia
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia
8Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia
Aurelio Barricarte
9CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
10Navarra Public Health Institute, Pamplona, Spain
11Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
Matthias W. Beckmann
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
Andrew Berchuck
13Department of Gynecologic Oncology, Duke University Hospital, Durham, NC, USA
Marina Bermisheva
14Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia
Marcus Q. Bernardini
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
Katharina Bischof
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Line Bjorge
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Clara Bodelon
18Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Alison H. Brand
19Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
20University of Sydney, Sydney, New South Wales, Australia
James D. Brenton
21Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Louise Brinton
18Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Fiona Bruinsma
22Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
Daniel D. Buchanan
23Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia
24Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
25Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia
26University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia
Stefanie Burghaus
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
Ralf Butzow
27Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
Hui Cai
28Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
Michael E. Carney
29John A. Burns School of Medicine, Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, HI, USA
Stephen J. Chanock
30Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
Chu Chen
31Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Xiao Qing Chen
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Zhihua Chen
32Department of Biostatistics, Moffitt Cancer Center, Tampa, FL, USA
Linda S. Cook
33University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM, USA
34Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada
Julie M. Cunningham
35Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Immaculata De Vivo
36Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Anna deFazio
19Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
Jennifer A. Doherty
39Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA
Thilo Dörk
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
Andreas du Bois
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany
42Praxis für Humangenetik, Wiesbaden, Germany
Alison M. Dunning
43Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK
Matthias Dürst
44Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany
Todd Edwards
45Division of Epidemiology, Center for Human Genetics Research, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Robert P. Edwards
46Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee- Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Arif B. Ekici
48Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
Ailith Ewing
2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Peter A. Fasching
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
49David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA
Sarah Ferguson
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
James M. Flanagan
50Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK
Florentia Fostira
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Athens, Greece
George Fountzilas
52Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessalon?ki, Greece
Christine M. Friedenreich
34Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, AB, Canada
Bo Gao
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
53The Crown Princess Mary Cancer Centre Westmead, Sydney-West Cancer Network, Westmead Hospital, Sydney, New South Wales, Australia
Mia M. Gaudet
54Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA
Jan Gawełko
55Intitute of Nursing and Health Sciences, Medical Faculty, University of Rzeszów, Rzeszów, Poland
Aleksandra Gentry-Maharaj
56MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK
Graham G. Giles
22Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
24Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
57Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
Rosalind Glasspool
58Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK
Marc T. Goodman
59Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Jacek Gronwald
60Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
61Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
62Peter MacCallum Cancer Center, Melbourne, Victoria, Australia
Holly R. Harris
63Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
64Department of Epidemiology, University of Washington, Seattle, WA, USA
Philipp Harter
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany
Alexander Hein
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
Florian Heitz
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany
Michelle A.T. Hildebrandt
65Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Peter Hillemanns
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
Estrid Høgdall
66Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
67Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
Claus K. Høgdall
68The Juliane Marie Centre, Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Elizabeth G. Holliday
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia
8Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia
David G. Huntsman
69British Columbia’s Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada
70Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
71Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada
72Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
Tomasz Huzarski
73Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland
74Department of Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland
Anna Jakubowska
60Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
75Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland
Allan Jensen
66Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
Michael E. Jones
76Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
Beth Y. Karlan
77David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA
Anthony Karnezis
78Department of Pathology and Laboratory Medicine, UC Davis Medical Center, Sacramento, CA, USA
Joseph L. Kelley
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Elza Khusnutdinova
14Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia
79Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia
Jeffrey L. Killeen
80Department of Pathology, Kapiolani Medical Center for Women and Children, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA
Susanne K. Kjaer
66Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
81Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Rüdiger Klapdor
82Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
Martin Köbel
83Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada
Bozena Konopka
84Department of Pathology and Laboratory Medicine, Institute of Oncology and Maria Sklodowska-Curie Cancer Center, Warsaw, Poland
Irene Konstantopoulou
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Athens, Greece
Reidun K. Kopperud
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Madhuri Koti
85Departments of Biomedical and Molecular Sciences and Obstetrics and Gynaecology, Cancer Biology and Genetics Division, Queen’s Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada
Peter Kraft
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
86Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Jolanta Kupryjanczyk
84Department of Pathology and Laboratory Medicine, Institute of Oncology and Maria Sklodowska-Curie Cancer Center, Warsaw, Poland
Diether Lambrechts
87VIB Center for Cancer Biology, Leuven, Belgium
88Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium
Melissa C. Larson
89Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Loic Le Marchand
90Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA
Shashikant B. Lele
91Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Jenny Lester
77David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA
Andrew J. Li
92Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars- Sinai Medical Center, Los Angeles, CA, USA
Dong Liang
93College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA
Clemens Liebrich
94Clinics of Gynaecology, Cancer Center Wolfsburg, Wolfsburg, Germany
Loren Lipworth
95Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Jolanta Lissowska
96Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center, Oncology Institute, Warsaw, Poland
Lingeng Lu
97Chronic Disease Epidemiology, Yale School of Medicine, New Haven, CT, USA
Karen H. Lu
98Department of Gynecologic Oncology and Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Alessandra Macciotta
99Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Amalia Mattiello
100Dipertimento Di Medicina Clinca e Chirurgia, Federico II University, Naples, Italy
Taymaa May
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
Jessica McAlpine
101British Columbia’s Ovarian Cancer Research (OVCARE) Program - Gynecologic Tissue Bank, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver General Hospital and BC Cancer, Vancouver, BC, Canada
Valerie McGuire
102Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA
Iain A. McNeish
103Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK
104Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Usha Menon
56MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK
Francesmary Modugno
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
105Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA
Kirsten B. Moysich
5Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA
Heli Nevanlinna
106Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
Kunle Odunsi
91Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Håkan Olsson
107Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden
Sandra Orsulic
92Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars- Sinai Medical Center, Los Angeles, CA, USA
Ana Osorio
108Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain
109Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Domenico Palli
110Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
Tjoung-Won Park-Simon
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
Celeste L. Pearce
111Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA
112Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
Tanja Pejovic
113Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA
114Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Jennifer B. Permuth
115Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA
Agnieszka Podgorska
84Department of Pathology and Laboratory Medicine, Institute of Oncology and Maria Sklodowska-Curie Cancer Center, Warsaw, Poland
Susan J. Ramus
116School of Women’s and Children’s Health, Faculty of Medicine, University of NSW Sydney, Sydney, New South Wales, Australia
117The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia
118Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia
Timothy R. Rebbeck
119Harvard T.H. Chan School of Public Health, Boston, MA, USA
120Dana-Farber Cancer Institute, Boston, MA, USA
Marjorie J. Riggan
13Department of Gynecologic Oncology, Duke University Hospital, Durham, NC, USA
Harvey A. Risch
97Chronic Disease Epidemiology, Yale School of Medicine, New Haven, CT, USA
Joseph H. Rothstein
121Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
122Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ingo Runnebaum
44Department of Gynaecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany
Rodney J. Scott
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia
123Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia
124Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia
Thomas A. Sellers
115Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA
Janine Senz
69British Columbia’s Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada
70Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
V. Wendy Setiawan
125Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Nadeem Siddiqui
126Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK
Weiva Sieh
121Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
122Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Beata Spiewankiewicz
127Department Obstetrics and Gynecology, Specialistic Hospital in Radom, Warsaw, Poland
Rebecca Sutphen
128Epidemiology Center, College of Medicine, University of South Florida, Tampa, FL, USA
Anthony J. Swerdlow
76Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
129Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
Lukasz Szafron
130Department of Immunology, the Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland
Soo Hwang Teo
131Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia
132Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Pamela J. Thompson
59Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Liv Cecilie Vestrheim Thomsen
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway
Linda Titus
133Geisel School of Medicine, Dartmouth College, Hanover, NH, USA
Alicia Tone
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
Rosario Tumino
134Cancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy
Constance Turman
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Adriaan Vanderstichele
135Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Digna Velez Edwards
136Division of Quantitative Sciences, Department of Obstetrics and Gynecology, Department of Biomedical Sciences, Women’s Health Research, Vanderbilt University Medical Center, Nashville, TN, USA
Ignace Vergote
135Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Robert A. Vierkant
89Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Zhaoming Wang
18Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Shan Wang-Gohrke
137Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany
Penelope M. Webb
61Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Emily White
64Department of Epidemiology, University of Washington, Seattle, WA, USA
138Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Alice S. Whittemore
102Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA
139Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA
Stacey J. Winham
89Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Xifeng Wu
65Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Anna H. Wu
125Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Drakoulis Yannoukakos
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Athens, Greece
Amanda B. Spurdle
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Tracy A. O’Mara
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Abstract
Accumulating evidence suggests a relationship between endometrial cancer and epithelial ovarian cancer. For example, endometrial cancer and epithelial ovarian cancer share epidemiological risk factors and molecular features observed across histotypes are held in common (e.g. serous, endometrioid and clear cell). Independent genome-wide association studies (GWAS) for endometrial cancer and epithelial ovarian cancer have identified 16 and 27 risk regions, respectively, four of which overlap between the two cancers. Using GWAS summary statistics, we explored the shared genetic etiology between endometrial cancer and epithelial ovarian cancer. Genetic correlation analysis using LD Score regression revealed significant genetic correlation between the two cancers (rG = 0.43, P = 2.66 × 10−5). To identify loci associated with the risk of both cancers, we implemented a pipeline of statistical genetic analyses (i.e. inverse-variance meta-analysis, co-localization, and M-values), and performed analyses by stratified by subtype. We found seven loci associated with risk for both cancers (PBonferroni < 2.4 × 10−9). In addition, four novel regions at 7p22.2, 7q22.1, 9p12 and 11q13.3 were identified at a sub-genome wide threshold (P < 5 × 10−7). Integration with promoter-associated HiChIP chromatin loops from immortalized endometrium and epithelial ovarian cell lines, and expression quantitative trait loci (eQTL) data highlighted candidate target genes for further investigation.
Competing Interest Statement
Usha Menon has stocks in Abcodia awarded to her by UCL. All other authors declare no potential conflicts of interest.
Funding Statement
TAO’M is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1111246) and Investigator Fellowship (APP1173170), ABS is supported by an NHMRC Senior Research Fellowship (APP1061779) and Investigator Fellowship (APP1177524). This work was supported by a Cancer Australia PdCCRS Project Grant, funded by Cure Cancer Australia and the CanToo Foundation (#1138084), NHMRC Project Grants (APP1158083 and APP1109286), QIMR Berghofer Medical Research Institute Near Miss Funding and a special purpose donation from gratefully received from Sarah Stork. Full ECAC and OCAC funding information can be found in the Supplementary Note.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial Support: TAO’M is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1111246) and Investigator Fellowship (APP1173170), ABS is supported by an NHMRC Senior Research Fellowship (APP1061779) and Investigator Fellowship (APP1177524). This work was supported by a Cancer Australia PdCCRS Project Grant, funded by Cure Cancer Australia and the CanToo Foundation (#1138084), NHMRC Project Grants (APP1158083 and APP1109286), QIMR Berghofer Medical Research Institute Near Miss Funding and a special purpose donation from gratefully received from Sarah Stork.
Conflict of Interest Statement: UM has stocks in Abcodia awarded to her by UCL. All other authors declare no potential conflicts of interest.
Data Availability
OCAC and ECAC summary statistics are available from the GWAS catalog. The E6E7hTERT HiChIP data are available from GEO and IOSE11 HiChIP data will be made available upon publication.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Posted May 07, 2020.
Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise Brinton, Fiona Bruinsma, Daniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, OPAL Study Group, AOCS Group, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant B. Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, V. Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle, Tracy A. O’Mara
medRxiv 2020.04.29.20084095; doi: https://doi.org/10.1101/2020.04.29.20084095
Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise Brinton, Fiona Bruinsma, Daniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, OPAL Study Group, AOCS Group, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant B. Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, V. Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle, Tracy A. O’Mara
medRxiv 2020.04.29.20084095; doi: https://doi.org/10.1101/2020.04.29.20084095
Subject Area
Subject Areas
- Addiction Medicine (79)
- Allergy and Immunology (223)
- Anesthesia (60)
- Cardiovascular Medicine (535)
- Dermatology (63)
- Emergency Medicine (185)
- Epidemiology (6205)
- Gastroenterology (247)
- Genetic and Genomic Medicine (1006)
- Geriatric Medicine (97)
- Health Economics (260)
- Health Informatics (836)
- Health Policy (443)
- Hematology (123)
- HIV/AIDS (204)
- Medical Education (135)
- Medical Ethics (29)
- Nephrology (109)
- Neurology (971)
- Nursing (53)
- Nutrition (159)
- Oncology (571)
- Ophthalmology (180)
- Orthopedics (48)
- Otolaryngology (116)
- Pain Medicine (56)
- Palliative Medicine (23)
- Pathology (160)
- Pediatrics (292)
- Primary Care Research (130)
- Public and Global Health (2495)
- Radiology and Imaging (421)
- Respiratory Medicine (346)
- Rheumatology (125)
- Sports Medicine (90)
- Surgery (126)
- Toxicology (25)
- Transplantation (42)
- Urology (44)